October 19th, 2011 by AndrewSchorr in Health Policy, Interviews
No Comments »
If you’ve read my blogs for a while, or look up some past blogs, you’ll see I have been frustrated at times with the FDA. Yes, they have a tough job protecting us from medical products that are unsafe and/or ineffective. But when it comes to cancer, where we have few “homerun” therapies, I wish they were a bit more liberal. A “bunt single” might be good enough. You may have read how I have been critical of Dr. Rick Pazdur, the FDA leader for oncology drug approval. Some desperate patients and family members have referred to him as “Dr. No.”
Just the other day I interviewed a respected breast cancer survivor and patient advocate who has high respect for Dr. Pazdur. Musa Mayer of New York City is a 22-year breast cancer survivor and author of three books about breast cancer. She’s devoted her life to educating other patients about cancer and also playing a role in public policy. She has become a favorite patient representative on FDA cancer advisory boards and regularly weighs in when breast cancer drugs are being considered.
In my interview with Musa, she explained Read more »
*This blog post was originally published at Andrew's Blog*
January 4th, 2011 by AndrewSchorr in Better Health Network, Health Tips, Opinion, Research
No Comments »
You are an individual right? To your mom and dad you are/were like no other. Hopefully your family and friends continue to see you as one-of-a-kind. Had you considered your doctor should see you that way too? Not as yet another one with diabetes, or heart disease, or cancer, but as a singular human being with biology that may be different from even the next person through the door with the same diagnosis.
This is the age of “personalized medicine” and it will accelerate in 2011. It is our responsibility as patients to ensure the power of this concept is leveraged for us each time we interact with the healthcare system. This is especially true as we manage a serious chronic condition or a cancer.
Now, in research and in clinical practice there are refined tests to determine what our specific version of a disease is and there are tests to see how a targeted therapy is working in our bodies. In other words, there’s the opportunity to see which therapy might be right for us that might be different than what is right for another person, and then there is the opportunity to monitor the therapy early on to see if it is doing its job. Read more »
*This blog post was originally published at Andrew's Blog*
January 13th, 2010 by Davis Liu, M.D. in Better Health Network, Health Tips, True Stories
No Comments »
I’ve always wanted to be a doctor.
Never a writer.
With a new year and a new decade, I am determined to become a better writer not because of some childhood dream or expectation from others, but because of a near mishap that occurred at the beginning of 2000. A simple phone call changed the destiny of my brother from having a good outcome to having a great outcome. A simple phone call may have been the difference between “you are cancer free” to “I’m sorry to tell you it’s come back.” Read more »
*This blog post was originally published at Saving Money and Surviving the Healthcare Crisis*
